David Turkaly
Stock Analyst at Citizens Capital Markets
(0)
# 4134
Out of 5,287 analysts
149
Total ratings
34.33%
Success rate
-6.88%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
TELA Bio | Maintains: Market Outperform | 12 7 | 1.39 | 403.6% | 6 | Mar 21, 2025 | |
OrthoPediatrics | Reiterates: Market Outperform | 50 50 | 24.9 | 100.8% | 10 | Mar 21, 2025 | |
Axogen | Reiterates: Market Outperform | 26 26 | 18.14 | 43.33% | 7 | Mar 5, 2025 | |
Integra Lifesciences | Reiterates: Market Outperform | 35 35 | 22.69 | 54.25% | 14 | Feb 26, 2025 | |
SI-BONE | Reiterates: Market Outperform | 32 32 | 14.83 | 115.78% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 2 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | n/a | n/a | n/a | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 125 100 | 64.53 | 54.97% | 9 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 16 16 | 9.53 | 67.89% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 112 112 | 99.46 | 12.61% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 265 265 | 223.03 | 18.82% | 15 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 14 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Outperform | 62 | 39.99 | 55.04% | 1 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 7 3 | 4.68 | -35.9% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 23 20 | 13.01 | 53.73% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 285 285 | 141.65 | 101.2% | 13 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 160 140 | 111.3 | 25.79% | 13 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 7 4 | 2.27 | 76.21% | 4 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 26 18 | n/a | n/a | 3 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 6 9 | n/a | n/a | 2 | Sep 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 5 | 8.38 | -40.33% | 1 | Oct 6, 2017 |